Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6

Tondreau, 2005, Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity, Stem Cells, 23, 1105, 10.1634/stemcells.2004-0330 Zuk, 2001, Multilineage cells from human adipose tissue: implications for cell-based therapies, Tissue Eng, 7, 211, 10.1089/107632701300062859 Campagnoli, 2001, Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow, Blood, 98, 2396, 10.1182/blood.V98.8.2396 Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Keating, 2006, Mesenchymal stromal cells, Curr Opin Hematol, 13, 419, 10.1097/01.moh.0000245697.54887.6f Jones, 2008, Immunosuppression by mesenchymal stromal cells: from culture to clinic, Exp Hematol, 36, 733, 10.1016/j.exphem.2008.03.006 Di Nicola, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182/blood.V99.10.3838 Le Blanc, 2003, Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex, Scand J Immunol, 57, 11, 10.1046/j.1365-3083.2003.01176.x Krampera, 2003, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, 101, 3722, 10.1182/blood-2002-07-2104 Nasef, 2008, Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms, Regen Med, 3, 531, 10.2217/17460751.3.4.531 Le Blanc, 2003, HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells, Exp Hematol, 31, 890, 10.1016/S0301-472X(03)00110-3 Ryan, 2007, Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, Clin Exp Immunol, 149, 353, 10.1111/j.1365-2249.2007.03422.x Tabera, 2008, The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes, Haematologica, 93, 1301, 10.3324/haematol.12857 Corcione, 2006, Human mesenchymal stem cells modulate B-cell functions, Blood, 107, 367, 10.1182/blood-2005-07-2657 Rasmusson, 2007, Mesenchymal stem cells stimulate antibody secretion in human B cells, Scand J Immunol, 65, 336, 10.1111/j.1365-3083.2007.01905.x Spaggiari, 2008, Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2, Blood, 111, 1327, 10.1182/blood-2007-02-074997 Nauta, 2006, Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells, J Immunol, 177, 2080, 10.4049/jimmunol.177.4.2080 Li, 2008, Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway, J Immunol, 180, 1598, 10.4049/jimmunol.180.3.1598 Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559 Di Ianni, 2008, Mesenchymal cells recruit and regulate T regulatory cells, Exp Hematol, 36, 309, 10.1016/j.exphem.2007.11.007 Tondreau, 2004, Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential, Cytotherapy, 6, 372, 10.1080/14653240410004943 D'Arena, 1999, Inability of activated cord blood T lymphocytes to perform Th1-like and Th2-like responses: implications for transplantation, J Hematother Stem Cell Res, 8, 381, 10.1089/152581699320135 Garcia Vela, 2000, Comparative intracellular cytokine production by in vitro stimulated T lymphocytes from human umbilical cord blood (HUCB) and adult peripheral blood (APB), Anal Cell Pathol, 20, 93, 10.1155/2000/572952 Han, 2004, Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40–CD40 ligand costimulatory pathway, Immunology, 113, 26, 10.1111/j.1365-2567.2004.01933.x Chadburn, 1992, The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells, Hematol Pathol, 6, 193 Smol'nikova, 2000, Cytokine-induced differentiation and proliferation of human T lymphocytes in vitro: effects of interleukin 2 and interleukin 6, Bull Exp Biol Med, 129, 567, 10.1007/BF02434879 Yonezawa, 2000, SDF-1 has costimulatory effects on human T cells: possible involvement of MAPK (ERK2) activation, Microbiol Immunol, 44, 135, 10.1111/j.1348-0421.2000.tb01256.x Djouad, 2003, Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals, Blood, 102, 3837, 10.1182/blood-2003-04-1193 Plumas, 2005, Mesenchymal stem cells induce apoptosis of activated T cells, Leukemia, 19, 1597, 10.1038/sj.leu.2403871 Puissant, 2005, Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells, Br J Haematol, 129, 118, 10.1111/j.1365-2141.2005.05409.x Wang, 1998, Cellular alloreactivity of human cord blood cells detected by T-cell frequency analysis and a human skin explant model, Transplantation, 66, 903, 10.1097/00007890-199810150-00015 Kurtzberg, 2009, Update on umbilical cord blood transplantation, Curr Opin Pediatr, 21, 22, 10.1097/MOP.0b013e32832130bc Macmillan, 2009, Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial, Bone Marrow Transplant, 43, 447, 10.1038/bmt.2008.348 Harris, 1992, Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes, Proc Natl Acad Sci USA, 89, 10006, 10.1073/pnas.89.21.10006 Li, 2007, Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells, Cell Tissue Res, 330, 437, 10.1007/s00441-007-0504-5 Fang, 2006, Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation, Transplantation, 82, 1370, 10.1097/01.tp.0000232450.62408.f9 Rasmusson, 2005, Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Exp Cell Res, 305, 33, 10.1016/j.yexcr.2004.12.013 Tse, 2003, Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, Transplantation, 75, 389, 10.1097/01.TP.0000045055.63901.A9 Krampera, 2006, Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells, Stem Cells, 24, 386, 10.1634/stemcells.2005-0008 Chan, 2006, Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma, Blood, 107, 4817, 10.1182/blood-2006-01-0057 Magatti, 2008, Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities, Stem Cells, 26, 182, 10.1634/stemcells.2007-0491 Eddahri, 2009, Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities, Blood, 113, 2426, 10.1182/blood-2008-04-154682 Traggiai, 2008, Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients, Stem Cells, 26, 562, 10.1634/stemcells.2007-0528 Selmani, 2008, Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells, Stem Cells, 26, 212, 10.1634/stemcells.2007-0554 Barrett, 2008, Prophylaxis of acute GVHD: manipulate the graft or the environment?, Best Pract Res Clin Haematol, 21, 165, 10.1016/j.beha.2008.02.004